🔎 Trials Near Me

Beranda › Penyakit Paru › Massachusetts › Boston

Uji klinis Penyakit Paru di Boston, MA

14 studi untuk Penyakit Paru mencari peserta di lokasi sekitar Boston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Menerima pesertaFase 3
  • Dana-Farber Cancer Institute, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06765109

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Menerima pesertaFase 3
  • Brigham and Women's Hospital, Boston
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Menerima pesertaFase 3
  • Brigham and Women's Hospital, Boston
  • Clinical Trials Center, Boston
  • Clinical Trials Hub, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07013474

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Menerima pesertaFase 2
  • Brigham and Women's Hospital, Boston
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07759245

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Menerima pesertaFase 1/2
  • Dana Farber Cancer Institute, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Menerima pesertaFase 3
  • Boston Medical Center, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Menerima pesertaFase 2
  • Clinical Research Site, Boston
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07333183

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

Menerima pesertaFase 2
  • Beth Israel Deaconess Medical Center, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT05967689

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Menerima pesertaFase 2
  • Dana-Farber Cancer Institute, Boston
  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT05922761

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Menerima pesertaFase 1/2
  • Massachusetts General Hospital,, Boston
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT03093116

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Menerima peserta
  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Feb 2026 · NCT02984761

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Menerima pesertaFase 2
  • Dana-Farber Cancer Institute, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Des 2025 · NCT06619561

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

Menerima peserta
  • Brigham and Women's Hospital, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2025 · NCT04555161

Uji klinis Penyakit Paru di kota lain

Studi lain di Boston

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.